...
首页> 外文期刊>CVIR Endovascular >Transcatheter arterial embolization for unruptured renal angiomyolipoma using a 1.8-Fr tip microballoon catheter with a mixture of ethanol and Lipiodol
【24h】

Transcatheter arterial embolization for unruptured renal angiomyolipoma using a 1.8-Fr tip microballoon catheter with a mixture of ethanol and Lipiodol

机译:用于乙醇和脂碘混合物的1.8-FR尖微型导管未破碎的肾血管脂瘤的经视截觉管动脉栓塞

获取原文
           

摘要

To evaluate the efficacy and safety of transcatheter arterial embolization for renal angiomyolipoma using a 1.8-French tip microballoon catheter and a mixture of ethanol and Lipiodol. Seven consecutive patients with total of eight angiomyolipomas underwent this procedure between June 2014 and June 2017. A 1.8-French tip microballoon catheter was advanced to the feeding artery of the angiomyolipoma, and transcatheter arterial embolization was performed with a mixture of ethanol and Lipiodol under microballoon inflation. We retrospectively evaluated the characteristics of angiomyolipomas, technical success rate, clinical success rate, renal function, and adverse events. Technical success and clinical success were defined as complete embolization of all feeding arteries and reduction of tumor size, respectively. The median size of the angiomyolipomas was 46?mm (range, 40–64?mm). Transcatheter arterial embolization was successful in all eight angiomyolipomas. The median volume of the mixture of ethanol and Lipiodol was 6.0?ml (range, 2.0–14?ml). The median ratio of ethanol to Lipiodol was 71% (range, 71–75%). All eight angiomyolipomas shrank with a median shrinkage rate of 34% in diameter (range, 9–63%) and 77% in volume (range, 48–94%). The median follow-up period was 13?months (range, 9–54?months). Clinical success was achieved in all cases. Serum creatinine concentrations and the pre- and post-procedural estimated glomerular filtration rates did not change notably, and there were no major complications. Transcatheter arterial embolization for renal angiomyolipoma using a 1.8-French tip microballoon catheter with a mixture of ethanol and Lipiodol is effective and safe.
机译:使用1.8-法国尖端微金子导管和乙醇和脂碘的混合物来评估经膜状管动脉栓塞对肾血管植物的疗效和安全性。总共八个血管玉米瘤的七名患者在2014年6月和2017年6月期间接受了这一程序。1.8-法国尖端微量导管前进至血管孢子素膜的饲喂动脉,并且在微量碘乙醇和脂碘的混合物下进行经截管动脉栓塞通货膨胀。我们回顾性地评估了血管肌醇脂肪酸,技术成功率,临床成功率,肾功能和不良事件的特征。技术成功和临床成功被定义为所有饲喂动脉的完全栓塞和减少肿瘤大小。血管肌醇脂肪酸的中值尺寸为46Ωmm(范围,40-64毫秒)。经导管动脉栓塞在所有八个血管血瘤中都是成功的。乙醇和脂碘混合物的中值体积为6.0?ml(范围,2.0-14ml)。乙醇与脂碘的中值比为71%(范围,71-75%)。所有八个血管肌醇脂肪症均匀缩小直径为34%(范围,9-63%)和77%(范围,48-94%)。中位后续期间为13?月(范围,9-54个月)。在所有情况下取得了临床成功。血清肌酐浓度和程序前和后后估计的肾小球过滤率并没有显着变化,并且没有主要的并发症。用于肾血管脂肪素瘤的经变性动脉栓塞使用1.8法国尖微相导管,具有乙醇和脂碘的混合物是有效和安全的。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号